Features of natural and gonadotropin-releasing hormone antagonist-induced corpus luteum regression and effects of in vivo human chorionic gonadotropin

被引:32
|
作者
Del Canto, Felipe
Sierralta, Walter
Kohen, Paulina
Munoz, Alex
Strauss, Jerome F., III
Devoto, Luigi
机构
[1] Univ Chile, Fac Med, Inst Invest Materno Infantil, Hosp Clin San Borja Arriaran, Santiago 3, Chile
[2] Univ Chile, INTA, Lab Ultraestruct, Santiago 3, Chile
[3] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA USA
来源
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2007年 / 92卷 / 11期
关键词
D O I
10.1210/jc.2007-0125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The natural process of luteolysis and luteal regression is induced by withdrawal of gonadotropin support. Objective: The objectives of this study were: 1) to compare the functional changes and apoptotic features of natural human luteal regression and induced luteal regression; 2) to define the ultrastructural characteristics of the corpus luteum at the time of natural luteal regression and induced luteal regression; and 3) to examine the effect of human chorionic gonadotropin ( hCG) on the steroidogenic response and apoptotic markers within the regressing corpus luteum. Design: Twenty- three women with normal menstrual cycles undergoing tubal ligation donated corpus luteum at specific stages in the luteal phase. Some women received a GnRH antagonist prior to collection of corpus luteum, others received an injection of hCG with or without prior treatment with a GnRH antagonist. Main Outcome Measure: Main outcome measures were plasma hormone levels and analysis of excised luteal tissue for markers of apoptosis, histology, and ultrastructure. Results: The progesterone and estradiol levels, corpus luteum DNA, and protein contents in induced luteal regression resembled those of natural luteal regression. hCG treatment raised progesterone and estradiol in both natural luteal regression and induced luteal regression. The increase in apoptosis detected in induced luteal regression by cytochrome c in the cytosol, activated caspase- 3, and nuclear DNA fragmentation, was similar to that observed in natural luteal regression. The antiapoptotic protein Bcl- 2 was significantly lower during natural luteal regression. The proapoptotic proteins Bax and Bak were at a constant level. Apoptotic and nonapoptotic death of luteal cells was observed in natural luteal regression and induced luteal regression at the ultrastructural level. hCG prevented apoptotic cell death, but not autophagy. Conclusion: The low number of apoptotic cells disclosed and the frequent autophagocytic suggest that multiple mechanisms are involved in cell death at luteal regression. hCG restores steroidogenic function and restrains the apoptotic process, but not autophagy.
引用
收藏
页码:4436 / 4443
页数:8
相关论文
共 50 条
  • [41] OVARIAN RESPONSE TO HUMAN CHORIONIC-GONADOTROPIN OR GONADOTROPIN-RELEASING-HORMONE IN CATS IN NATURAL OR INDUCED ESTRUS
    GOODROWE, KL
    WILDT, DE
    THERIOGENOLOGY, 1987, 27 (05) : 811 - 817
  • [42] GONADOTROPIN-RELEASING HORMONE TEST AND HUMAN CHORIONIC-GONADOTROPIN TEST IN THE DIAGNOSIS OF GONADOTROPIN-DEFICIENCY IN PREPUBERTAL BOYS
    DUNKEL, L
    PERHEENTUPA, J
    VIRTANEN, M
    MAENPAA, J
    JOURNAL OF PEDIATRICS, 1985, 107 (03): : 388 - 392
  • [43] Hormone-induced sperm-release in the critically endangered Booroolong frog (Litoria booroolongensis): effects of gonadotropin-releasing hormone and human chorionic gonadotropin
    Silla, Aimee J.
    McFadden, Michael S.
    Byrne, Phillip G.
    CONSERVATION PHYSIOLOGY, 2019, 7
  • [44] Comparison of the effects of gonadotropin-releasing hormone, human chorionic gonadotropin and progesterone on conception rates in repeat breeder dairy cows
    Farzaneh, N.
    Rhoramian, B.
    Mohri, M.
    Garousi, M. Talebkhan
    PROCEEDINGS OF THE FORTIETH ANNUAL CONFERENCE AMERICAN ASSOCIATION OF BOVINE PRACTITIONERS, 2007, : 299 - 299
  • [45] EFFECTS OF GONADOTROPIN-RELEASING HORMONE AND ESTROGEN ON SERUM LEVELS OF HUMAN CHORIONIC GONADOTROPIN-LIKE SUBSTANCE IN POSTMENOPAUSAL WOMEN
    NAKANO, R
    YAMOTO, M
    NISHI, T
    FUJINAGA, H
    FERTILITY AND STERILITY, 1990, 54 (01) : 161 - 163
  • [46] Combined Administration of Gonadotropin-releasing Hormone Agonist with Human Chorionic Gonadotropin for Finall Oocyte Maturation in GnRH Antagonist Cycles for in Vitro Fertilization
    Kim, Chung-Hoon
    Ahn, Jun-Woo
    You, Rae-Mi
    Kim, Sung-Hoon
    Chae, Hee-Dong
    Kang, Byung-Moon
    JOURNAL OF REPRODUCTIVE MEDICINE, 2014, 59 (1-2) : 63 - 68
  • [47] Gonadotropin-Releasing Hormone Agonist Versus Recombinant Human Chorionic Gonadotropin Triggering in Fertility Preservation Cycles
    Herzberger, Einat Haikin
    Knaneh, Sabaa
    Amir, Hadar
    Reches, Adi
    Ben-Yosef, Dalit
    Kalma, Yael
    Azem, Foad
    Samara, Nivin
    REPRODUCTIVE SCIENCES, 2021, 28 (12) : 3390 - 3396
  • [48] Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program
    Erb, Teresa M.
    Vitek, Wendy
    Wakim, Anthony N. G.
    FERTILITY AND STERILITY, 2010, 93 (02) : 374 - 378
  • [49] GONADOTROPIN-RELEASING HORMONE (GNRH) STIMULATES HUMAN CHORIONIC-GONADOTROPIN (HCG) RELEASE IN TROPHOBLASTIC DISEASE
    MACARON, C
    FREINKEL, N
    BREWER, J
    WILBER, JF
    KAHAN, B
    HALPERN, B
    CLINICAL RESEARCH, 1976, 24 (03): : A274 - A274
  • [50] EFFECTS OF A GONADOTROPIN-RELEASING HORMONE ANTAGONIST ON GONADOTROPIN-SECRETION AND GONADAL DEVELOPMENT IN NEONATAL PIGS
    ZIECIK, AJ
    ESBENSHADE, KL
    BRITT, JH
    JOURNAL OF REPRODUCTION AND FERTILITY, 1989, 87 (01): : 281 - 289